New Delhi, May 16 -- Indian government scientists say they have achieved a breakthrough in attempts to develop an indigenous therapy for treating Nipah virus patients.

Also Read | HMPV virus: How doctors are using social media, humour to educate people

Scientists familiar with the matter said the Indian Council of Medical Research (ICMR) has held successful animal trials with the country's first indigenously developed monoclonal antibodies (mAbs) to treat Nipah virus patients.

The virus, which is commonly transmitted from fruit bats, has a high mortality rate. Currently, India imports monoclonal antibodies from Queensland, Australia. These are administered intravenously.

Also Read | Kerala: Nipah virus case confirmed in Malappuram dis...